Dongdong Tian

Title: Innovations of Dongdong Tian in Pharmaceutical Development

Introduction

Dongdong Tian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target CRTH2 receptors. With a total of two patents to his name, his work is paving the way for new treatments in this area.

Latest Patents

Dongdong Tian's latest patents include a tricyclic compound as a CRTH2 inhibitor. This patent provides a tricyclic compound, or its pharmaceutically acceptable salt, tautomer, stereoisomer, or solvate, for use in treating diseases related to CRTH2 receptors. Another notable patent is for an indole derivative used as a CRTH2 inhibitor. This application discloses an indole, represented by a specific formula, which is also used in treating diseases related to CRTH2 receptors.

Career Highlights

Dongdong Tian is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this esteemed company has allowed him to focus on innovative pharmaceutical solutions. His research and inventions are crucial in advancing medical treatments.

Collaborations

Some of his notable coworkers include Bin Chen and Yuanshan Yao. Their collaboration contributes to the innovative environment at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conclusion

Dongdong Tian's contributions to pharmaceutical innovations, particularly in CRTH2 inhibitors, highlight his role as a key inventor in the industry. His patents reflect a commitment to advancing medical science and improving patient outcomes.